Trexquant Investment LP

Position in SRRK — Scholar Rock Holding Corp

CIK 1633445 STAMFORD, CT

Position in SRRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,164,160

+$11,391,229 QoQ

Shares Held

275,712

+259.2% QoQ

Ownership

0.226%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#57

of 304 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. SRRK ranks #7 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp This page	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,164,160	275,712	+259.2%	Shares	Sole	2026-08-14
2026-03-31	$3,772,931	76,748	+56.9%	Shares	Sole	2026-05-15
2025-12-31	$2,155,234	48,927	-14.3%	Shares	Sole	2026-02-17
2025-03-31	$1,835,957	57,106	-15.9%	Shares	Sole	2025-05-14
2024-12-31	$2,936,107	67,934	-54.6%	Shares	Sole	2025-02-12
2024-09-30	$1,198,976	149,685	-45.1%	Shares	Sole	2024-11-12
2024-06-30	$2,272,382	272,795	+97.6%	Shares	Sole	2024-08-13
2024-03-31	$2,452,158	138,072	+91.0%	Shares	Sole	2024-05-14
2023-12-31	$1,358,958	72,285	+321.3%	Shares	Sole	2024-02-09
2022-09-30	$118,904	17,158	-37.0%	Shares	Sole	2022-11-14
2022-06-30	$149,404	27,214	+120.9%	Shares	Sole	2022-08-11
2022-03-31	$158,830	12,322	+59.4%	Shares	Sole	2022-05-13
2021-03-31	$391,652	7,731	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.